Adiponectin reduces immune checkpoint inhibitor-induced inflammation without blocking anti-tumor immunity
Year: 2025
Type: article
Study design: Clinical Trial
DOI: 10.5167/uzh-284598
Authors: Braun, Lukas M., Giesler, Sophie, Andrieux, Geoffroy, Riemer, Roxane, Talvard-Balland, Nana, Duquesne, Sandra, Rückert, Tamina, Unger, Susanne, Kreutmair, Stefanie, Zwick, Melissa, Follo, Marie, Hartmann, Alina, Osswald, Natascha, Melchinger, Wolfgang, Chapman, Stefanie, Hutchinson, James A., Haferkamp, Sebastian, Torster, Leopold, Kött, Julian, Gebhardt, Christoffer, Hellwig, Dirk, Karantzelis, Nikolaos, Wallrabenstein, Till, Lowinus, Theresa, Yücel, Mehtap, Brehm, Niklas, Rawluk, Justyna, Pfeifer, Dietmar, Bronsert, Peter, Rogg, Manuel, et al, Becher, Burkhard
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7127632869